ScholarIQanswers from OpenAlex
Universidad de Las Palmas de Gran Canaria
InstitutionResearch output, impact & collaborations
Universidad de Las Palmas de Gran Canaria is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universidad de Las Palmas de Gran Canaria?
ScholarIQrecord summary
Universidad de Las Palmas de Gran Canaria is a research organisation in Las Palmas de Gran Canaria, ES. OpenAlex records 24,635 works and 1,127,805 citations for it. 5,844 researchers list it as their most recent affiliation.
How many works does Universidad de Las Palmas de Gran Canaria have?
ScholarIQindexed works
Universidad de Las Palmas de Gran Canaria has 24,635 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universidad de Las Palmas de Gran Canaria have?
ScholarIQcitation count
Universidad de Las Palmas de Gran Canaria has 1,127,805 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universidad de Las Palmas de Gran Canaria?
ScholarIQresearcher count
Universidad de Las Palmas de Gran Canaria has 5,844 researchers in the ScholarIQ index.
What is the average h-index at Universidad de Las Palmas de Gran Canaria?
ScholarIQavg h-index
Universidad de Las Palmas de Gran Canaria has an average h-index of 48.5 in OpenAlex.
What is the ROR of Universidad de Las Palmas de Gran Canaria?
ScholarIQror
The ROR for Universidad de Las Palmas de Gran Canaria is on the source record.
What is the OpenAlex record for Universidad de Las Palmas de Gran Canaria?
ScholarIQopenalex
The OpenAlex for Universidad de Las Palmas de Gran Canaria is on the source record.
What is the Wikidata of Universidad de Las Palmas de Gran Canaria?
ScholarIQwikidata
The Wikidata for Universidad de Las Palmas de Gran Canaria is on the source record.
Who are the most-cited researchers behind Universidad de Las Palmas de Gran Canaria?
ScholarIQtop researchers by citations
What are the most-cited papers on Universidad de Las Palmas de Gran Canaria?
ScholarIQmost cited works
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Ramón Estruch, Emilio Ros, Jordi Salas‐Salvadó, María‐Isabel Covas, Dolores Corella, Fernando Arós, Enrique Gómez‐Gracia, Valentina Ruíz-Gutiérrez, Miquel Fiol, José Lapetra, Rosa M. Lamuela‐Raventós, Lluís Serra‐Majem, Xavier Pintó, Josep Basora, Miguel Ángel Muñoz, José V. Sorlí, J. Alfredo Martínéz, Miguel Ángel Martínez‐González
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo, Francesco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez‐Abreu, Denis Moro‐Sibilot, Christian A. Thomas, Fabrice Barlési, Gene Grant Finley, Claudia Kelsch, Anthony Lee, Shelley Coleman, Yu Deng, Yijing Shen, Marcin Kowanetz, Ariel López-Chávez, Alan Sandler, Martin Reck
How much of the research on Universidad de Las Palmas de Gran Canaria is open access?
ScholarIQopen access share
100%OPEN ACCESS